SINOVAC BIOTECH LTD (SVA) Return on equity 2016–2025
SINOVAC BIOTECH LTD (SVA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-4.5%FY2025 · since FY2016: -0.5% → -4.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4.5% | -5.0 pp |
| FY2024 | 0.5% | +0.7 pp |
| FY2023 | -0.2% | -0.3 pp |
| FY2022 | 0.2% | -90.1 pp |
| FY2021 | 90.3% | +75.5 pp |
| FY2020 | 14.8% | -0.5 pp |
| FY2019 | 15.3% | +6.7 pp |
| FY2018 | 8.6% | -8.5 pp |
| FY2017 | 17.1% | +17.6 pp |
| FY2016 | -0.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice